# Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
**Date:** 2026-01-20 14:13:00
**Company:** GSK plc
**Ticker:** GSK
**Source URL:** https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html
---
[Accessibility: Skip TopNav](https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html#maincontainer)
[](https://www.globenewswire.com/)
- [Newsroom](https://www.globenewswire.com/newsroom)
- [Services](https://www.globenewswire.com/services)
- [Contact Us](https://insight.notified.com/globenewswire-contact-us?utm_medium=Website&utm_source=Contact%20Us&utm_campaign=...
# Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
**Date:** 2026-01-20 14:13:00
**Company:** GSK plc
**Ticker:** GSK
**Source URL:** https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html
---
[Accessibility: Skip TopNav](https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html#maincontainer)
[](https://www.globenewswire.com/)
- [Newsroom](https://www.globenewswire.com/newsroom)
- [Services](https://www.globenewswire.com/services)
- [Contact Us](https://insight.notified.com/globenewswire-contact-us?utm_medium=Website&utm_source=Contact%20Us&utm_campaign=Contact%20Us%20ENG)
- English
[Sign In](https://www.globenewswire.com/home/signin) [Register](https://portal.notified.com/en/registration)
# [](https://www.forbion.com/)
# Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
January 20, 2026 14:13 ET\| Source:
[Forbion](https://www.globenewswire.com/en/search/organization/Forbion)FollowForbion
* * *
Share
- * * *
NAARDEN, The Netherlands, Jan. 20, 2026 (GLOBE NEWSWIRE) -- [Forbion](https://www.globenewswire.com/Tracker?data=mNZF5bslBYstqRXVNoEpflysN-VLh16YQCh_X-R6FO09DHGop3v-lh5UuN0rstXxKWcxq5OqSfiMdAiWumto1w== "Forbion"), a leading life sciences venture capital firm with deep roots in Europe, today announces that GSK (NYSE: GSK) has entered into a definitive agreement to acquire Forbion Growth Fund III portfolio company RAPT Therapeutics, Inc. (NASDAQ: RAPT) in a transaction valued at $2.2 billion.
“Our investment in RAPT Therapeutics reflects this approach, combining deep scientific conviction with disciplined capital deployment in the public markets.…”
“Forbion Growth Fund III was established to back differentiated, late-stage assets with clear clinical value and strong strategic relevance,”
“Our investment in RAPT Therapeutics reflects this approach, combining deep scientific conviction with disciplined capital deployment in the public markets.…”
“Forbion Growth Fund III was established to back differentiated, late-stage assets with clear clinical value and strong strategic relevance,”
“Our investment in RAPT Therapeutics reflects this approach, combining deep scientific conviction with disciplined capital deployment in the public markets.…”
RAPT Therapeutics was a recent, undisclosed investment within Forbion Growth Fund III’s public value opportunities strategy and represents the fund’s second exit. The transaction follows the acquisition of Astria Therapeutics by BioCryst for $920 million in October 2025, further underscoring the fund’s strong momentum and execution capabilities.
The acquisition highlights significant strategic interest in RAPT’s lead therapeutic candidate, ozureprubart, a long-acting monoclonal antibody designed to neutralize IgE, a key driver of severe allergic disease. Ozureprubart has the potential to meaningfully transform the treatment landscape for allergies and other immunologic conditions, including chronic spontaneous urticaria (CSU). The program is currently in late-stage clinical development, with a Phase 2b trial ongoing in food allergy and a Phase 3 trial in CSU expected to commence in 2026.
“Forbion Growth Fund III was established to back differentiated, late-stage assets with clear clinical value and strong strategic relevance,” **said Mathias Vinther, PhD, Partner at Forbion**. “Our investment in RAPT Therapeutics reflects this approach, combining deep scientific conviction with disciplined capital deployment in the public markets. The outcome announced today demonstrates the value of early engagement, active ownership and a long-term perspective in building positions in high-quality companies.”
This transaction reinforces Forbion’s growth strategy of backing differentiated, late-stage clinical assets in areas of high unmet medical need with clear strategic relevance to global pharmaceutical companies. It also serves as a strong example of the fund’s public markets sub-strategy, which focuses on identifying and capitalizing on attractive public value opportunities.
The closing of the transaction is expected to occur in the first quarter of 2026, subject to customary conditions. The official press release issued by GSK and RAPT Therapeutics can be found [here](https://www.globenewswire.com/Tracker?data=Rv6shLnkml3o0CG8sobYXmtuflanXDg3PrhPC22P_IYyti7jc4AdbiEEfzAP_KXw3WHepfkYzcxfTJvQj-EkFyP3otZZsOhs8Qwiw9X-Me-H8YKFZOMMkiFC2w0csU8XeFCtrpVKU2hJ6B6HgIkt2ciG47Wty2fk0ojpipKV9Z3GYbKi-qeqw5OSXa38H-lD "here").
**About Forbion**
Forbion is a leading global venture capital firm with deep roots in Europe and offices in Naarden, the Netherlands, Munich, Germany, and Boston, USA. Forbion invests in innovative biotech companies, managing approximately €5 billion across multiple fund strategies covering all stages of (bio)pharmaceutical drug development. In addition to its human health focus, Forbion also invests in planetary health solutions through its BioEconomy strategy. The firm’s team of over 30 investment professionals has a strong track record, with more than 130 investments across 11 funds, resulting in numerous approved therapies and successful exits. Forbion is a signatory to the UN Principles for Responsible Investment and operates a joint venture with BGV for seed and early-stage investments in the Benelux and Germany regions.
**For more information, please contact:**
**Forbion Communications**
Email: laura.asbjornsen@forbion.com
Head of Marketing & Communications
* * *
## Tags
[exit](https://www.globenewswire.com/en/search/tag/exit "exit")[finance](https://www.globenewswire.com/en/search/tag/finance "finance")[biotech](https://www.globenewswire.com/en/search/tag/biotech "biotech")[lifesciences](https://www.globenewswire.com/en/search/tag/lifesciences "lifesciences")[pharma](https://www.globenewswire.com/en/search/tag/pharma "pharma")
GlobeNewswire
Company ProfileForbionIndustry: FinancialsWebsite:
[https://www.forbion.com](https://www.forbion.com/)
Press Release Actions
- [Print](https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html?print=1)
- [Download PDF](https://www.globenewswire.com/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html?pdf=1)
- [Subscribe via RSS](https://www.globenewswire.com/rssfeed/organization/tSPH1ipheEPM27s9YKtvKg==)
- [Subscribe via ATOM](https://www.globenewswire.com/atomfeed/organization/tSPH1ipheEPM27s9YKtvKg==)
- [Javascript](https://www.globenewswire.com/JSWidget/organization/7pGai-lUmwL_lU6s3UrqlA%3d%3d)
[View More News](https://www.globenewswire.com/en/newsroom)
## Explore
Previous
[](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html)
March 03, 2026 15:57 ET
[Toll Brothers Announces Final Opportunity to Own a...](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html "Toll Brothers...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html)
March 03, 2026 15:20 ET
[Witte Museum Brings '90s Nostalgia to Life with Th...](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html "Witte Museum Brings...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html)
March 03, 2026 15:18 ET
[SUCCESS® Releases Digital Edition Dedicated to the...](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html "SUCCESS® Releases...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248950/0/en/Kraken-Robotics-Announces-Signing-of-Strategic-Acquisition-to-Expand-Global-Maritime-Capabilities.html)
March 03, 2026 16:18 ET
[Kraken Robotics Announces Signing of Strategic Acq...](https://www.globenewswire.com/news-release/2026/03/03/3248950/0/en/Kraken-Robotics-Announces-Signing-of-Strategic-Acquisition-to-Expand-Global-Maritime-Capabilities.html "Kraken Robotics...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248903/0/en/Coherent-Executives-to-Showcase-Thought-Leadership-at-OFC-CTO-Julie-Eng-to-Deliver-the-Plenary-Session.html)
March 03, 2026 16:05 ET
[Coherent Executives to Showcase Thought Leadership...](https://www.globenewswire.com/news-release/2026/03/03/3248903/0/en/Coherent-Executives-to-Showcase-Thought-Leadership-at-OFC-CTO-Julie-Eng-to-Deliver-the-Plenary-Session.html "Coherent Executives...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html)
March 03, 2026 15:57 ET
[Toll Brothers Announces Final Opportunity to Own a...](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html "Toll Brothers...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html)
March 03, 2026 15:20 ET
[Witte Museum Brings '90s Nostalgia to Life with Th...](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html "Witte Museum Brings...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html)
March 03, 2026 15:18 ET
[SUCCESS® Releases Digital Edition Dedicated to the...](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html "SUCCESS® Releases...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248950/0/en/Kraken-Robotics-Announces-Signing-of-Strategic-Acquisition-to-Expand-Global-Maritime-Capabilities.html)
March 03, 2026 16:18 ET
[Kraken Robotics Announces Signing of Strategic Acq...](https://www.globenewswire.com/news-release/2026/03/03/3248950/0/en/Kraken-Robotics-Announces-Signing-of-Strategic-Acquisition-to-Expand-Global-Maritime-Capabilities.html "Kraken Robotics...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248903/0/en/Coherent-Executives-to-Showcase-Thought-Leadership-at-OFC-CTO-Julie-Eng-to-Deliver-the-Plenary-Session.html)
March 03, 2026 16:05 ET
[Coherent Executives to Showcase Thought Leadership...](https://www.globenewswire.com/news-release/2026/03/03/3248903/0/en/Coherent-Executives-to-Showcase-Thought-Leadership-at-OFC-CTO-Julie-Eng-to-Deliver-the-Plenary-Session.html "Coherent Executives...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html)
March 03, 2026 15:57 ET
[Toll Brothers Announces Final Opportunity to Own a...](https://www.globenewswire.com/news-release/2026/03/03/3248885/0/en/Toll-Brothers-Announces-Final-Opportunity-to-Own-a-Luxury-Townhome-at-Mira-Vista-in-San-Diego-California.html "Toll Brothers...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html)
March 03, 2026 15:20 ET
[Witte Museum Brings '90s Nostalgia to Life with Th...](https://www.globenewswire.com/news-release/2026/03/03/3248862/0/en/Witte-Museum-Brings-90s-Nostalgia-to-Life-with-The-Robot-Zoo.html "Witte Museum Brings...")
[](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html)
March 03, 2026 15:18 ET
[SUCCESS® Releases Digital Edition Dedicated to the...](https://www.globenewswire.com/news-release/2026/03/03/3248861/0/en/SUCCESS-Releases-Digital-Edition-Dedicated-to-the-Power-of-Coaching.html "SUCCESS® Releases...")
Next
About Us
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.
Global News
- [English](https://www.globenewswire.com/newsroom)
- [Français](https://www.globenewswire.com/fr/newsroom)
- [Deutsch](https://www.globenewswire.com/de/newsroom)
Newswire Distribution Network & Management
- [Home](https://www.globenewswire.com/)
- [Newsroom](https://www.globenewswire.com/newsroom)
- [RSS Feeds](https://www.globenewswire.com/rss/list)
- [Notified](https://www.notified.com/)
- [Legal](https://www.notified.com/privacy)
- [Contact us](https://insight.notified.com/globenewswire-contact-us?utm_medium=Website&utm_source=Contact%20Us&utm_campaign=Contact%20Us%20ENG)
- [Resources](https://www.notified.com/resources)
© 2026 Digital Media Innovations, LLC. All rights reserved.
[GlobeNewswire Linkedin](https://www.linkedin.com/company/1006947 "GlobeNewswire Linkedin") [Notified Twitter](https://twitter.com/Notified "Notified Twitter")
;
[Français](https://www.globenewswire.com/fr/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html) [Deutsch](https://www.globenewswire.com/de/news-release/2026/01/20/3222209/0/en/Forbion-Announces-Second-Exit-from-Forbion-Growth-Fund-III-Following-2-2-Billion-Acquisition-of-RAPT-Therapeutics-by-GSK.html)